In short, CEOs can't be afraid to walk away from their most profitable line if another approach may lead to improved long-term outcomes.
When his mother suffered from ovarian cancer a decade ago, Robert Herjavec found himself frustrated by the quality of care she received.
Otsuka, Astellas, Takeda, and Daiichi Sankyo share a degree of adventurousness and forward-mindedness in the digital realm.
Tech companies and Bernie Sanders have found the millennial audience easy to crack. Organizations in and around healthcare? Not so much.
The organizations are using innovation competitions to challenge internal and external audiences with coming up with new ideas.
He knew from his fractured childhood that courage in the face of adversity translated into survival and that empathy must be embedded in care and cures.
It's a common refrain in healthcare and among patients, providers, and payers: Despite massive investment, no one has figured out how to change human behavior.
Immuno-oncology drugs showing results in hard-to-treat cancers; Express Scripts responds to Anthem lawsuit; BI and Lilly plan outcomes trials for Jardiance
Innovation leaders in the healthcare sector say hire experienced staff, centralize your team, and encourage women in innovation to rise up the C-suite.
Healthcare innovation teams are at a unique point. They've moved from ideating to innovating and have structured themselves accordingly.
Learn about Merck's new innovation team as well as read profiles of 9 other teams at companies such as Google and Johnson & Johnson.
There are big changes underway in the doctor-patient relationship, a study suggests, and it's a new reality to which biopharma must adjust.
The deadline has been extended to April 8.
Here's my biggest gripe: Innovation teams should be driving innovation for their particular business, not just for marketing and communications.
Life-sciences companies often behave as though focusing on patient needs is simply a matter of asking, "How can we provide patients with more services?
Hackathons are a dime a dozen in healthcare. But are they encouraging the community to collaborate on solving the most nettlesome problems, or merely to tinker on me-too solutions?
Executives at Eli Lilly, Merck and Biogen used the most recent earnings season to promote innovation and defend drug pricing.
Pharma's internal innovation units often look externally for ideas that can transform the business. Here, the director of Pfizer's worldwide innovation group describes how he imported an approach to help sustain skill development within the network.
- Veeva and QuintilesIMS tussle over customer reference data
- What five different pharma marketing careers look like
- Five things for pharma marketers to know: Monday, March 27, 2017
- Patients are taking on DTC ads. How will drugmakers respond?
- Five things for pharma marketers to know: Tuesday, March 28, 2017
- 2017 Healthcare Marketers Trend Report: All the data in one place
- Infographic: What's next for the point of care market
- Drugmakers again boost DTC spending, to $5.6 billion in 2016
- Digital IDs become focus as drugmakers seek to track doctors' behavior online
- Some CME experts remain skeptical when it comes to social media
- Cannes Lions announces pharma, health and wellness juries
- McCann Health's June Laffey on why change is good in health
- Five things for pharma marketers to know: Thursday, March 30, 2016
- Drummy passes the torch at Heartbeat, moves to chairman role
- Five things for pharma marketers to know: Wednesday, March 29, 2017